Prothena

balloon missed target pop arrows miss failure
Biotech

Prothena reburies drug after 2nd swing at rare disease misses

The phase 3 trial missed its primary endpoint, prompting the biotech to end development and plan a “substantial reduction in organizational size.”
Nick Paul Taylor May 27, 2025 3:33am
long shot miss basketball hoop fail shoot

Roche's Prothena-partnered Parkinson's prospect fails phase 2b

Dec 19, 2024 4:31am
cellos without players

UCB-Novartis Parkinson's asset fails to improve symptoms in ph. 2

Dec 16, 2024 3:19pm
Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky North- Vietnam

Prothena promotes one exec while another leaves—Chutes & Ladders

Oct 4, 2024 8:00am
Inspector uses a magnifying glass for inspecting papers

NIH leader's research misconduct calls drugs into question

Sep 26, 2024 9:12am
check list to do list yes okay schedule

Bristol Myers checks 'yes' on Prothena neurodegenerative therapy

May 29, 2024 10:38am